Lupus erythematosus comprises a spectrum of autoimmune diseases that may affect various
organs (systemic lupus erythematosus [SLE]) or the skin only (cutaneous lupus …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and a relapsing-remitting course. New data regarding pathogenic …

Background Systemic lupus erythematosus (SLE) is heterogeneous in organ involvement
and disease severity, presenting a broad clinical phenotype. Systemic type I interferon (IFN) …

The immunologic drivers of cutaneous lupus erythematosus (CLE) and its clinical subtypes
remain poorly understood. We sought to characterize the immune landscape of discoid …

Introduction There are no US Food and Drug Administration (FDA) approved therapies for
cutaneous lupus erythematosus (CLE). Litifilimab is a monoclonal antibody against BDCA2 …

Introduction Cutaneous lupus erythematosus (CLE) is an autoimmune disease that is
clinically heterogenous and may occur with or without the presence of systemic lupus …

Granzymes (granule-secreted enzymes) are a family of serine proteases that have been
viewed as redundant cytotoxic enzymes since their discovery more than 30 years ago …

Cutaneous lupus erythematosus (CLE) is an autoimmune disorder like systemic lupus
erythematosus (SLE). Both SLE and CLE characterize autoantibody secretion and immune …

Cutaneous lupus erythematosus (CLE) is an inflammatory and autoimmune skin condition
that affects patients with systemic lupus erythematosus (SLE) and exists as an isolated entity …

Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using
highly multiplexed imaging mass cytometry Comprehensive analysis of cell lineages involved in …